Clinical Trials
- Liver, Genetics
Genetic Studies of Polycystic Livers
- Ages18 years and older
- GenderBoth
- Liver
Saroglitazar Primary Biliary Cholangitis
- Liver
A Phase 3 Study Evaluating Long-term Efficacy and Safety of Lanifibranor in Adult Patients With (NASH) and Fibrosis 2 (F2)/Fibrosis 3 (F3) Stage of Liver Fibrosis (NATiV3)
- Ages18 years and older
- GenderBoth
- Liver, Obesity & Weight Management
Pathophysiology of Nonalcoholic Fatty Liver Disease (NAFLD) in Youth with Obesity
- Ages12 years - 22 years
- GenderBoth